Horizon Kinetics Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.65M Sell
3,965
-141
-3% -$143K 0.04% 83
2025
Q4
$4.41M Sell
4,106
-141
-3% -$135K 0.06% 73
2025
Q3
$3.24M Buy
4,247
+141
+3% +$105K 0.04% 86
2025
Q2
$3.2M Sell
4,106
-151
-4% -$117K 0.04% 93
2025
Q1
$3.52M Hold
4,257
0.04% 85
2024
Q4
$3.29M Buy
4,257
+141
+3% +$117K 0.04% 94
2024
Q3
$3.65M Sell
4,116
-141
-3% -$127K 0.05% 87
2024
Q2
$3.85M Sell
4,257
-500
-11% -$400K 0.07% 75
2024
Q1
$3.7M Buy
4,757
+2
+0% +$1.42K 0.07% 73
2023
Q4
$2.77M Sell
4,755
-422
-8% -$246K 0.06% 78
2023
Q3
$2.78M Sell
5,177
-260
-5% -$134K 0.06% 79
2023
Q2
$2.55M Buy
+5,437
New +$2.28M 0.05% 91
2023
Q1
Sell
-6,886
Closed -$2.52M 345
2022
Q4
$2.52M Sell
6,886
-500
-7% -$177K 0.04% 88
2022
Q3
$2.39M Hold
7,386
0.05% 84
2022
Q2
$2.4M Hold
7,386
0.05% 89
2022
Q1
$2.12M Hold
7,386
0.04% 116
2021
Q4
$2.04M Sell
7,386
-1,000
-12% -$254K 0.04% 122
2021
Q3
$1.94M Hold
8,386
0.05% 122
2021
Q2
$1.93M Hold
8,386
0.04% 130
2021
Q1
$1.57M Sell
8,386
-2,768
-25% -$541K 0.04% 142
2020
Q4
$1.88M Sell
11,154
-1,000
-8% -$149K 0.06% 117
2020
Q3
$1.8M Sell
12,154
-1,000
-8% -$155K 0.07% 119
2020
Q2
$2.16M Hold
13,154
0.08% 101
2020
Q1
$1.82M Hold
13,154
0.08% 92
2019
Q4
$1.73M Hold
13,154
0.05% 120
2019
Q3
$1.47M Hold
13,154
0.04% 134
2019
Q2
$1.46M Sell
13,154
-4,100
-24% -$483K 0.04% 142
2019
Q1
$2.24M Buy
+17,254
New +$2.1M 0.06% 110

Other funds holding LLY

Horizon Kinetics Asset Management's LLY Position: Q1 2026 in Review

Horizon Kinetics Asset Management reduced its Eli Lilly (LLY) stake by 3.4% in Q1 2026, selling an estimated $143K and leaving 3,965 shares worth $3.65M. The position accounts for 0.04% of the portfolio, ranked #83.

Horizon Kinetics Asset Management first reported a position in LLY in Q1 2019 and has held it in 28 quarters since. The position peaked at $4.41M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Horizon Kinetics Asset Management held 3,965 shares of Eli Lilly worth $3.65M as of Q1 2026.
  • Horizon Kinetics Asset Management sold 141 Eli Lilly shares in Q1 2026, an estimated $143K.
  • Eli Lilly made up 0.04% of Horizon Kinetics Asset Management's portfolio in Q1 2026, its #83 holding.
  • Horizon Kinetics Asset Management first reported a position in Eli Lilly in Q1 2019 and has held it in 28 quarters since.
  • Horizon Kinetics Asset Management's Eli Lilly position peaked at $4.41M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2026, filed 15 May 2026.